InvestorsHub Logo
Followers 56
Posts 2632
Boards Moderated 0
Alias Born 02/01/2017

Re: longfellow95 post# 287183

Thursday, 06/04/2020 1:00:25 PM

Thursday, June 04, 2020 1:00:25 PM

Post# of 688913
Hi Longfellow,

Many thanks for your input. I think you are right in believing that with alphapuppy's model = reality, we would have had way back then an AA in hand.

I am now looking at this in a very simplistic way.

There are plenty of records indicating that many patients who received DCVax-L and became post 5 year survivors, unfortunately suffered the final event within the following years.

Obviously, while the rate of progression diminishes with time, it is unfortunately still alive and well for many years.

I nevertheless suspect that in comparison to SOC and other treatments, DCVax-L at every timeline effects a greater decrease in the rate of progression.

I hope that the published results of this trial will give us a better understanding of the effect DCVax-L has on the rates of progression during different timelines of the GBM illness.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News